The FDA has approved a new sunscreen ingredient, bemotrizinol. It marks the first U.S. sunscreen innovation since 1999. Bemotrizinol is a chemical filter designed to protect skin from both UVA and UVB rays.
The ingredient has been used globally for years. It is common in sunscreens across Europe, Asia, and Australia. Its delayed arrival in the U.S. stems from strict FDA approval processes for sun protection ingredients.
Bemotrizinol offers broad-spectrum protection. It blocks high-energy UV rays effectively. The filter also provides photostability, meaning it does not degrade quickly in sunlight.
This approval could lead to new sunscreen formulations. American consumers may soon see products with this ingredient. Manufacturers will need to meet specific guidelines to include it in products.
The ingredient is considered safe for most skin types. It does not absorb deeply into the skin. Clinical studies support its low irritation potential.
The approval addresses long-standing consumer demand. Many sought access to advanced filters already available abroad. Bemotrizinol provides an alternative to older chemical blockers.
Sunscreen options may expand further. The FDA continues reviewing other pending ingredients. Bemotrizinol represents a step toward modernizing U.S. sun protection standards.
